Clinical Trials Logo

Filter by:
NCT ID: NCT01545557 Completed - Clinical trials for Volume Loss (Soft Tissue Ptosis or Atrophy )

Pan Facial Volume Restoration

EVE
Start date: February 21, 2012
Phase: N/A
Study type: Interventional

The aim of this study is to assess performance and tolerance as well as investigator and subject satisfaction further to pan-facial volume restoration with a new cross-linked hyaluronic acid dermal filler containing lidocaine 0.3%.

NCT ID: NCT01544933 Completed - Clinical trials for Burst Thoracic Spine Fractures

The Influence of the Ribs on the Gravity of Burst Thoracic Spine Fractures

Start date: February 2011
Phase: N/A
Study type: Observational

The purpose of this study is to analyse the anatomic influence of the ribs related to the incidence and severity of burst spine fractures.

NCT ID: NCT01544491 Completed - Clinical trials for Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Start date: August 17, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if everolimus combined with reduced exposure CNI (TAC) is efficacious and safe and will support corticosteroid elimination compared to a standard exposure CNI (TAC) + MMF + steroid regimen after paediatric kidney transplantation. An additional purpose of the study is to assess the effect of the combination of EVR and reduced exposure CNI (TAC) on renal function. This study is part of the requirements of the Paediatric Investigational Plan approved by Paediatric Committee at the European Medicines Agency (PDCO/EMA) on September 10, 2010, and is intended to support the indication of everolimus in the prevention of acute rejection in paediatric recipients of a renal transplant.

NCT ID: NCT01543555 Completed - Clinical trials for Myocardial Infarction

Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose

LOAD
Start date: November 2012
Phase: Phase 3
Study type: Interventional

Patients submitted to noncardiac surgeries are at increased risk of serious cardiovascular complications. Statins have shown to lower cholesterol levels and reduce cardiovascular events in other scenarios. The objective of this study is to explore the effects of atorvastatin, as compared with placebo, on the 30-day risk of a composite of death, nonfatal Myocardial Injury after Noncardiac Surgery (MINS), or stroke among patients who undergo noncardiac surgery.

NCT ID: NCT01543399 Completed - Menopause Clinical Trials

Vascular Effect of Tibolone in the Brachial Artery

TDILA
Start date: March 2012
Phase: N/A
Study type: Interventional

The interruption of the secretion of sex steroids occurring during menopause, causes a change in vascular pattern at various levels. As a result, several agencies have side effects that interfere with women's health. The use of hormone replacement therapy has contributed to the improvement in these effects. In previous studies the investigators showed the effect of sex steroids in premenopausal women in the conjugated equine estrogens, medroxyprogesterone acetate and tibolone in menopausal women, on the central retinal arteries. The aim of this study is to evaluate the effects of Tibolone in Flow-Mediated Dilatation of the brachial artery.

NCT ID: NCT01542190 Completed - Clinical trials for Cystoid Macular Edema Following Cataract Surgery, Bilateral

Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery

Start date: February 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare effects of preoperative and postoperative use of topical ketorolac tromethamine 0.4% versus placebo in uncomplicated cataract surgery. Patients scheduled to undergo phacoemulsification will be randomized to receive either topical prednisolone acetate 1% 4 times daily (QID) plus dextran 70/hypromellose QID (placebo group) or topical prednisolone 1% QID plus ketorolac tromethamine 0.4% QID (ketorolac group) for three days preoperatively and four weeks postoperatively. The primary outcome 5 weeks after surgery will be angiographic cystoid macular edema.

NCT ID: NCT01541215 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes

Ellipseā„¢
Start date: November 13, 2012
Phase: Phase 3
Study type: Interventional

This trial is conducted globally. The aim of this trial is to assess the efficacy and safety of liraglutide in the paediatric population in order to potentially address the unmet need for treatment of children and adolescents with type 2 diabetes.

NCT ID: NCT01541124 Completed - Chronic Pain Clinical Trials

Morphine as First Drug for Cancer Pain

Start date: August 2008
Phase: N/A
Study type: Interventional

Background and Objectives: The drugs used as recommended by the WHO does not promote pain relief for all patients with cancer pain. The objective of this study was to evaluate the use of morphine as the first drug for the treatment of moderate cancer pain by visual analogue scale in patients with advanced disease and / or metastases, as an alternative to the recommendations of the WHO analgesic ladder advocated. Methods: The patients without opioid therapy with more than 18 years, were randomly divided into two groups. G1 patients received medication according to the analgesic ladder, starting treatment with non-opioid in the first step, the second weak opioid and opioid potent in the third, and G2 received morphine as first analgesic. There was evaluated the efficacy and tolerability of initial use of morphine every 2 weeks for 3 months. Results: The study was performed in 63 patients. The groups had similar demographics.

NCT ID: NCT01541111 Completed - Clinical trials for Cancer-related Problem/Condition

Magnesium Associated With Morphine for Cancer Pain Relief

Start date: January 2011
Phase: N/A
Study type: Interventional

This study is an evaluation of the analgesic effect of magnesium associated with morphine in patients with cancer pain.

NCT ID: NCT01540305 Completed - Clinical trials for Obsessive Compulsive Disorder

Efficacy Study of Transcranial Magnetic Stimulation for Treatment of Obsessive-Compulsive Disorder

Start date: May 2011
Phase: Phase 2
Study type: Interventional

This study aimed at verifying whether sessions of repetitive transcranial magnetic stimulation over a certain brain area (the supplementary motor area) could be useful in the relief of Obsessive-Compulsive Disorder symptoms.